Fox Run Management »

Akero Therapeutics shares owned by Fox Run Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Fox Run Management from 13F filings

Historical chart of Fox Run Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Fox Run Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $324k 13k 25.26
2023-03-31 $303k 7.9k 38.26

More positions owned by Fox Run Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr U.s. Real Es Etf (IYR)
Workday Cl A (WDAY)
Ecolab (ECL)
International Paper Company (IP)
Advance Auto Parts (AAP)
Vulcan Materials Company (VMC)
Nextracker Class A Com (NXT)
Post Holdings Inc Common (POST)
Baxter International (BAX)
Roku Com Cl A (ROKU)
Unum (UNM)
Willis Towers Watson SHS (WTW)

View all positions for Fox Run Management

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics